Clinical Trial Update: Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma [Phase 2]

View source ↗

Summary

Phase 2b trial update for RAPA-201 cell therapy in melanoma, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• RAPA-201

Snippet

Sponsor: Rapa Therapeutics LLC | Conditions: Malignant Melanoma With Metastasis, Malignant Melanoma | Phase 2 | Status: NOT_YET_RECRUITING